secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2025-04-28T23:59:59+00:00
Accession:  0001641172-25-006428
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell closes $13.8M public offering of units with warrants
-------------------------------------------------------------

- Gross proceeds of ~$13.8M from 3,066,666 units at $4.50/unit, including 399,999 from over-allotment
- Each unit consists of one common share (or pre-funded warrant) and one warrant exercisable at $5.25 for five years
- Warrants commenced trading on Nasdaq under BCTXZ on April 25, 2025
- Net proceeds to be used for working capital, general corporate purposes, and advancing business objectives
- ThinkEquity acted as sole book-running manager; offering closed on April 28, 2025

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000164117225006428/0001641172-25-006428-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000164117225006428/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-006428

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer